Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma
Jean Yves Blay, Claire Cropet, Sandrine Mansard, Yohann Loriot, Christelle de la Fouchardière, Julien Haroche, Delphine Topart, David Tougeron, Benoît You, Antoîne Italiano, Valérie Le Brun-Ly, Jean-Marc Ferrero, Nicolas Penel, Michel Fabbro, Xavier Troussard, David Malka, Isabelle Ray‐Coquard, Sophie Leboulleux, Aude Fléchon, E. Maubec, J. Charles, Stéphane Dalle, S. Taïeb, Gabriel Garcia, A.M. Mandache, N. Colignon, Marie Gavrel, F. Nowak, N. Hoog Labouret, Céline Mahier - Aït Oukhatar, Carlos Gomez‐Roca (2023). Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma. , 8(6), DOI: https://doi.org/10.1016/j.esmoop.2023.102038.
